Scrip Asks… What Does 2023 Hold For Biopharma? Part 4: Pricing And Reimbursement
Advanced Therapies And IRA Transform Landscape
Biopharma executives see value-based pricing as an increasingly important topic for the sector in 2023, while the US Inflation Reduction Act will have a major impact on portfolio strategies.
